Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-03-31
1994-11-15
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 62, A61K 31715, A61K 3170
Patent
active
053648455
ABSTRACT:
A therapeutic composition for the protection, treatment and repair of connective tissue in mammals and a method for the treatment of connective tissue in mammals by the administration of the composition. The composition includes glucosamine and preferably chondroitin sulfate. The composition further includes manganese ascorbate which catalyzes the production of collagen and proteoglycans from the glucosamine and the chondroitin sulfate.
REFERENCES:
patent: 3232836 (1966-02-01), Carlozzi et al.
patent: 3371012 (1968-02-01), Furuhashi
patent: 3683076 (1972-08-01), Rovati
patent: 3697652 (1972-10-01), Rovati et al.
patent: 4006224 (1977-02-01), Prudden
patent: 4414202 (1983-11-01), Silvelli
patent: 4486416 (1984-12-01), Soll et al.
patent: 4647453 (1987-03-01), Meisner
patent: 4772591 (1988-09-01), Meisner
patent: 4801619 (1989-01-01), Lindblad
patent: 4983580 (1991-01-01), Gibson
patent: 5141928 (1992-08-01), Goldman
patent: 5162303 (1992-11-01), Goodman
"Chondroproductive Agents Glucosamine Salts and Chondroitin Sulfates", Luke R . Bucci, Townsend Letters for Doctors, Jan. 1994, pp. 52-54.
Christensen, "Nutritional Support for Three Phases of Rehabilitation" Chiropractic Products, pp. 100-102, Apr. 1993.
Murray, "A Natural Treatment of Osteoarthritis", MPI's Dynamic Chiropractic, pp. 8-10, Sep. 12, 1993.
Morrison, et al., "Cornonary Heart Disease and the Mucopolysaccharides (Glycosaminoglycans)", C. C. Thomas, Publisher, 1974, pp. 109-127.
Drovanti et al, "Therapeutic Activity of Oral Glucosamine Sulfate in Osteoarthrosis; A Placebo-Controlled Double-Blind Investigation", Clin Therap. 3 (4) 260-272 (1980).
Karzel et al, "Effects of Hexosamine Derivatives and Uronic Acid Derivatives on Glycosaminoglycane Metabolism of Fibroblast Cultures", Pharmocol. 5, 337-345 (1971).
"Current Therapy in Equine Medicine", Robinson, Editor, W. B. Saunders Co., Publisher, pp. 402-403 (1987).
Garrison, Jr., et al, "The Nutrition Desk Reference", Keats Publishing, Inc., pp. 70-71 (1985).
Bucci, "Manganese: Its Role in Nurtitional Balance", Today's Chirop., 17 (2) 23-28, 44 (1988).
Bucci, "Glucosamine-A New Potent Nutraceutical For Connective Tissues", The Nutritional Supplement Advisor, Jul. 1992.
Banks, "Applied Veterinary Histology", Williams and Wilkins Publisher, pp. 84-85 (1986).
Setnikar et al, "Pharmakinetics of Glucosamine in the Dog and in Man", Arzneimittelforschung 38 (2) 729-736 (1991).
Vidal y Plana et al, "Articular Cartilage Pharmacology: I. In Vitro Studies on Glucosamine and Non-Steroidal Anti-inflammatory Drugs", Pharm. Res. Comm., 10 (6) 557-569 (1978).
Anon., "Using a Chondroprotective Drug in Treating Dogs With Osteochondrosis", Veterin. Med., 130 (1993).
Bloom Leonard
Cintins Marianne M.
Criares T. J.
Nutramax Laboratories, Inc.
LandOfFree
Glucosamine, chondroitin and manganese composition for the prote does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucosamine, chondroitin and manganese composition for the prote, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucosamine, chondroitin and manganese composition for the prote will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097834